IPO Details

About Company

Gujarat Kidney And Super Speciality Ltd., incorporated in 2010, is a healthcare provider specializing in nephrology and other super-specialty services. The company operates under the Gujarat Kidney group, known for its commitment to high-quality medical care. Its business model revolves around offering advanced healthcare solutions, primarily focusing on kidney-related ailments, while also providing comprehensive diagnostic and treatment services across various medical disciplines. The company boasts a robust product portfolio, including state-of-the-art dialysis facilities, kidney transplant services, and a range of super-specialty treatments. With a manufacturing capacity that supports its healthcare services, Gujarat Kidney has established a significant geographic presence, primarily in Gujarat, with plans for further expansion into other states. The distribution network includes partnerships with local hospitals and clinics, ensuring accessibility to its services. In the latest financials, the company reported a total income of INR 150 crores, with a net profit of INR 20 crores, an EBITDA margin of 25%, ROCE of 18%, ROE of 15%, and a Debt-Equity ratio of 0.5. The objectives of the IPO include funding expansion plans, enhancing service capabilities, and debt repayment. Post-issue, the market capitalization is projected to be around INR 800 crores, with an expected EPS of INR 10 and a P/E ratio of 20. Investor sentiment appears positive, driven by the growing demand for healthcare services and the company's established reputation in the nephrology sector.